Author: Dr. David Lowemann

Lilly Pill Leads to 8 Percent Weight Loss in Trial

Eli Lilly said on Thursday its experimental pill, orforglipron, led to a weight loss of nearly 8% at the highest dose and lowered blood sugar for overweight patients with Type 2 diabetes in a late-stage trial. Shares of the company jumped nearly 13% in premarket… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, […]

Published on April 17, 2025

Expert Panel Makes RSV, Meningitis Vaccines Recs

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. The Advisory Committee on Immunization Practices also voted to recommend a shot to protect… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on April 16, 2025

Is my green your green?

‘Do we see colors the same way?’ is a fundamentally human question and one of great importance in research into the human mind. While impossible to answer at present, researchers take steps to answering it using a method that can map the experiences of colors between individuals, including those with colorblindness. Read Full Article (External […]

Published on April 16, 2025